Harwood Private Equity achieved a full exit from its position in Bionostics Limited through a sale of the company to a trade buyer on 23 July 2013, creating a return of 4.0x cash multiple and an IRR of 30%.
Bionostics is an industry-leading developer, manufacturer and distributor of liquid control solutions employed in medical diagnostic testing equipment. Harwood Private Equity acquired the business in a public-to-private transaction in 2008.